The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, Georgios Germanidis
Topics & Concepts
MedicineCirrhosisHepatocellular carcinomaSorafenibBioinformaticsInternal medicineIntensive care medicinePharmacologyBiologyLiver Disease Diagnosis and TreatmentDrug Transport and Resistance MechanismsNeuroendocrine Tumor Research Advances